Theorem Clinical Research

Study Conduct

ACRES, HealthCarePoint strengthen partnership

Wednesday, February 5, 2014 01:18 PM

HealthCarePoint (HCP), a Texas-based healthcare and clinical research networking-technology company, and the Alliance for Clinical Research Excellence and Safety (ACRES), a Cambridge-based nonprofit organization dedicated to enhancing quality, safety, integrity and operational effectiveness in drug development and health research, have announced a second step in their previously announced strategic alliance.

More... »


Janssen R&D launches novel trial data sharing agreement with Yale School of Medicine

Thursday, January 30, 2014 10:49 AM

Johnson & Johnson subsidiary Janssen Research and Development has entered into a novel agreement with Yale School of Medicine's Open Data Access (YODA) Project to extend its commitment to sharing clinical trials data to enhance public health and advance science and medicine. 

More... »


TransCelerate releases update on risk-based monitoring initiative

Thursday, January 30, 2014 10:43 AM

In its continued effort to modernize and streamline the way clinical trials are conducted and monitored, TransCelerate BioPharma has providing the first update to its position paper outlining a methodology for risk-based site monitoring (RBM) released in June 2013.

More... »

New ACRP/CenterWatch partnership underway

Monday, January 27, 2014 02:55 PM

As promised when the partnership was announced mere months ago, a wealth of new resources intended to increase and broaden the market intelligence materials available to Association of Clinical Research Professionals (ACRP) members is now online (www.acrpnet.org/newresources), thanks to ACRP's collaboration with CenterWatch, a leading provider of information about clinical trials to both professionals and patients.

More... »

inVentiv Health, ViS Research partner

Monday, January 27, 2014 01:32 PM

inVentiv Clinical Trial Recruitment Solutions (iCTRS), an inVentiv Health company helping the biopharmaceutical sector reduce time to the start of clinical trials, has announced that the process innovations offered by its partnership with ViS could cut in half the time required to conduct feasibility studies.

More... »

LifeSciencesUK: Strategy of U.K. Life Sciences has more to accomplish

Friday, January 24, 2014 11:45 AM

A review of the government's Strategy for U.K. Life Sciences has found eight out of the 13 initiatives reviewed have made notable progress toward the actions and commitments set out in the original strategy, but there is still much more work to do to meet the strategy's original objectives.

More... »

Drug developers implementing new comparator strategies in clinical trials

Wednesday, January 22, 2014 12:37 PM

Drug developers are aggressively implementing new strategies to improve their access to and use of comparator drugs, which are used in clinical trials to determine how development candidates compare to existing therapies, according to leaders in the research-based drug industry who recently participated in a roundtable discussion convened by the Tufts Center for the Study of Drug Development (CSDD).

More... »

Award to honor Woman of the Year

Tuesday, January 21, 2014 11:13 AM

IIR Partnerships has launched a new award program to honor a Woman of the Year, to be presented in conjunction with the 3rd Annual Women’s Clinical Leadership Forum, Monday, March 31, at the 22nd Annual Partnerships in Clinical Trials conference in Las Vegas.

More... »

Former U.K. AstraZeneca R&D site to become science, technology park

Monday, January 20, 2014 11:56 AM

Loughborough, U.K., will be the location for a world-class science and technology park as development of a former AstraZeneca R&D site gets underway. Jayplas acquired the site in 2012 and has confirmed its plans to develop the site into a science park to be known as The Charnwood Biomedical Campus.

More... »

BIA comments on Fresh Start report

Friday, January 17, 2014 11:43 AM

Commenting on the Fresh Start report on the E.U. impact on the U.K. life science sector, Steve Bates, CEO of the BioIndustry Association (BIA), a trade association for innovative enterprises involved in U.K. bioscience, said, “This well researched report by George Freeman is right to point out that the E.U. is seen as an enlightened and progressive region for investing in biomedical research and that E.U. membership gives U.K.-based life science companies access to the single market and a uniform regulatory system for the development and approval of therapies.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 20

Toronto Star, with FDA data, exposes weaknesses in Health Canada's clinical trial, inspection oversight

Crowdsourcing effort aims to fund updated online social media guide for sponsor interaction with patients

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs